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Serial two-dimensional echocardiography was performed to 
detect left ventricular thrombus in 92 consecutive patients 
with a confirmed first acute anterior myocardial infarction. 
Thirty left ventricular thrombi were diagnosed in these 92 
patients. The cumulative percent of identified thrombus in 
each echocardiographic examination in the surviving pa- 
tients was 27% at ~24 h; 57% at 48 to 72 h; 75% at 1 week 
and 96% at 2 weeks. The thrombus shape was defined as 
mural in 53% and protruding in 47% of patients. Systemic 
embolism (stroke) was noted during hospitalization in two 
patients with a protruding thrombus. 
At 12 weeks of follow-up, patients with thrombus had 
poorer (and almost unchanged from baseline) global left 
ventricular function as expressed by wall motion score 
compared with that of patients without thrombus, who 
exhibited significant improvement. Global left ventricular 
wall motion in patients with persisting or resolved throm- 
bus was similar during follow-up. Apical wall motion 
worsened in 70% of the patients with persisting thrombus 
and in 25% of the patients with resolved thrombus (p < 
0.1). In the 22 surviving patients with thrombus, resolution 
Two-dimensional echocardiography has proved to be a reli- 
able tool in the diagnosis of left ventricular thrombus (l-3). 
Many investigators (4-19) have studied the pathogenesis of 
left ventricular thrombus and the effect of different anti- 
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or change in thrombus shape or size was noted in 14 of the 
15 patients receiving anticoagulant therapy and in 4 of the 
7 untreated patients. Six of the 18 patients with an early- 
(48 to 72 h) and none of the 12 patients with a later-formed 
thrombus died. Maximal serum enzyme levels, percent with 
Killip functional class III to IV and left ventricular wall 
motion score were higher in the patients with an early- than 
in those with a later-formed thrombus. 
Thus, left ventricular thrombus was found in 33% of 
patients with a first anterior myocardial infarction. Throm- 
bus formation within 48 to 72 h was associated with a poor 
prognosis. Two-dimensional echocardiography performed 
the 3rd day and after 2 weeks had the most clinical value in 
assessing early prognosis and identifying left ventricular 
thrombus. The presence or absence of thrombus was 
strongly correlated with a change in left ventricular func- 
tion during follow-up. In patients treated with oral antico- 
agulant agents, 93% of the left ventricular thrombi showed 
resolution or change in size or shape. 
(J Am Co11 Cardiol1989;13:1514-20) 
thrombotic regimens. Only a few studies (1,18,20-25) have 
prospectively investigated with serial two-dimensional echo- 
cardiography the prognostic significance of left ventricular 
thrombus and the occurrence of spontaneous or drug- 
induced regression of the left ventricular thrombus in a large 
group of patients. 
We performed serial two-dimensional echocardiography 
at short intervals during the acute phase of anterior myocar- 
dial infarction and after 12 weeks in a consecutive series of 
100 patients. The objectives of the study were 1) to identify 
patients at risk for left ventricular thrombus by means of 
echocardiographic and clinical data, and 2) to study the 
relation between the left ventricular wall motion, the occur- 
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rence and regression of thrombus, thrombus shape and the 
effect of treatment with oral anticoagulant agents. 
Methods 
Study patients. With serial two-dimensional echocardiog- 
raphy, we studied 100 consecutive patients with a first acute 
anterior myocardial infarction and interpretable echocardio- 
graphic images. The diagnosis of acute anterior myocardial 
infarction was based on the following criteria: a typical 
history of angina1 pain, elevation of serum creatine kinase 
(CK) and creatine kinase isoenzyme (MB CK) and charac- 
teristic electrocardiographic (ECG) changes with r2 mm ST 
segment elevation in leads V, to V, or ~1 mm elevation in 
lead I or aVL, or both. The diagnosis of first anterior 
myocardial infarction was based on the patient’s history 
and interpretation of the first ECG. Of the 100 patients, 8 
were excluded from the study (5 who did not develop myo- 
cardial infarction, I whose echocardiographic images were 
of poor quality and 2 who died before the first echocardio- 
gram). 
All 92 patients received standard coronary care. Anti- 
thrombotic therapy consisted of aspirin in 50 patients (part of 
a randomized placebo-controlled trial), heparin (5.000 IIJ 
twice daily subcutaneously during immobilization in all 
patients) and thrombolytic therapy (streptokinase, 1.5 x IO6 
IU intravenously) in patients ~71 years old who were 
admitted within 4 h after the onset of symptoms. 
Collected clinical data were clinical or hemodynamic 
Killip classification, maximal serial CK, MB CK and lactate 
dehydrogenase (LDH) levels. occurrence of systemic embo- 
lism and ventricular arrhythmia and the use of beta- 
adrenergic blocking agents or calcium channel antagonists. 
Oral mnticoug~4lunt therucpy was given after detection of 
left ventricular thrombus in patients with no contraindication 
for oral anticoagulation. It was begun after the fourth echo- 
cardiogram at hospital discharge and was managed by a 
special outpatient laboratory. The thrombotest was kept 
between 120 and 150 s. 
Two-dimensional echocardiography. In the 92 patients, a 
total of 379 two-dimensional echocardiographic examina- 
tions were performed at ~24 h, 48 to 72 hours and 1, 2 and 
12 weeks after the onset of symptoms. Echocardiograms 
were obtained with an ADR 4000 or ATL Mark VIII or 
HP-77020A ultrasound system with a mechanical or phased 
array sector scan with use of 2.5. 3.5 and 5 MHz transduc- 
ers. Optimal gain setting and reject control were used. A 
systematic echocardiographic examination, performed with 
the patients in the left supine position, included multiple 
parasternal short-axis views and apical two, three and four 
chamber views (Fig. 1). 
Left \lentriculrrr thrombus H’as dejined as an echo-dense 
mass in the left ventricular cavity, distinguishable in at least 
two views and attached to an asynergic left ventricular wall 
Figure 1. Apical two (2C), three (3C) and four (4C) chamber views 
of the left ventricle on two-dimensional echocardiography. The left 
ventricle (LV) is divided into 13 segments. Left ventricular wall 
motion score is calculated from the cumulative numeric score of 
each segment: normokinesia = 0, hypokinesia = + I. akinesia = t?, 
dyskinesia = t!. aneurysm = t4, hyperkinesia = - 1. LA = left 
atrium: RA = right atrium; RV = right ventricle. 
segment (26). The shape of the thrombus was described as 
mural if its free margin was concave and followed the 
curvature of the left ventricular wall. If its blood interface 
showed a curvature opposite to that of the left ventricular 
wall, the shape was termed protruding. The thrombus was 
defined as mobile if it showed motion independent of that of 
the adjacent left ventricular wall segment. A significant 
decrease in thrombus shape and size was defined, respec- 
tively, as a change from protruding to mural and a >5 mm 
decrease in maximal thickness. Measurement of maximal 
thrombus thickness was made perpendicular to the myocar- 
dium from the epicardial-pericardial interface to the inner- 
most border of thrombus-blood interface. 
All images were stored on videotape and interpreted at 
the end of the entire study without knowledge of date by two 
independent observers experienced in echocardiography. 
When images were equivocal, the interpretation of a third 
investigator was decisive. 
Left ventricular wall motion analysis. Wall motion was 
assessed from the echocardiographic short-axis and apical 
two. three and four chamber views. In these two- 
dimensional planes, the left ventricle was divided into 13 
segments as previously described (Fig. I) (26). The left 
ventricular wall motion score was calculated from a numeric 
score of each segment on the basis of the wall motion during 
systole (normal = 0, hypokinetic = + 1. akinetic = t2, 
dyskinetic = +3, aneurysm = +4, hyperkinetic = - 1). Left 
ventricular wall motion was scored by two observers; when 
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Figure 2. Number of patients studied with serial two-dimensional 
echocardiography (2DE) during the 12 week follow-up period. lost = 
lost to follow-up (acute cholecystitis in 1, admission to another 
hospital in 3, not cooperative or living in another area in 6 patients), 
LVT = left ventricular thrombus; MI = myocardial infarction; pts = 
patients; * = died. 
the result was equivocal, the score was averaged. Interob- 
server agreement was 93%. 
Results 
Incidence of left ventricular thrombus. Figure 2 summa- 
rizes the number of patients who were followed up by 
two-dimensional echocardiography or were lost to the study 
or died during the study period. With serial echocardiog- 
raphy, a cumulative number of 8, 18, 24, 29 and 30 left 
ventricular thrombi were detected in the 92 patients. We 
calculated the percent of identified thrombus at each echo- 
cardiographic examination in the surviving patients (re- 
solved thrombi not included). The cumulative percents was 
27% (8 of 30) at ~24 h; 57% (16 of 28) at 48 to 72 h; 75% (18 
of 24) at 1 week and 96% (22 of 23) at 2 weeks. Thus, an 
echocardiogram performed approximately 2 weeks after the 
onset of symptoms offered the best chance to detect persist- 
ing left ventricular thrombus in patients surviving anterior 
myocardial infarction. 
Left ventricular thrombus shape, treatment and follow-up. 
Figure 3 indicates the shape of the thrombus at first detection 
and the change in shape or resolution during follow-up and 
the relation to anticoagulant therapy. In 53% of patients, the 
shape of the thrombus was mural only, and in 47%, the 
Thmmbus shape 
PfOtWdillQ mural 
II48-72h 
Figure 3. Follow-up data in 30 patients with left ventricular throm- 
bus. Relation of clinical course to thrombus shape and treatment 
with oral anticoagulation. t = died. 
thrombus was protruding in one or more echocardiographic 
examinations. Transient thrombus mobility was noted in 
three patients. During the hospitalization period, five 
thrombi showed a change in shape and two resolved spon- 
taneously. Oral anticoagulant therapy was started in the 3rd 
and 4th weeks after infarction in seven of the nine patients 
with a protruding thrombus and resulted in thrombus reso- 
lution, decrease in size and change in shape in two, one and 
three patients, respectively. Eight of the 11 patients with a 
mural thrombus were given an anticoagulant; in 6 the throm- 
bus resolved and in 2 it decreased in size. In 7 of the 20 
patients with left ventricular thrombus who were not treated 
with an oral anticoagulant, two thrombi showed resolution 
during hospitalization, two resolved during follow-up and 
three remained unchanged or increased in size. 
The use of aspirin did not influence the incidence of left 
ventricular thrombus. In both the aspirin (n = 45) and the 
placebo (n = 47) groups 1.5 thrombi were found. No differ- 
ence was observed in the number of left ventricular thrombi 
detected in patients receiving streptokinase (15 of 43) and 
those without thrombolytic therapy (15 of 49) in the acute 
phase of myocardial infarction. 
Left ventricular wall motion. Figure 4 shows left ventric- 
ular wall motion in patients with or without left ventricular 
thrombus in one of the five echocardiographic studies ob- 
tained. These results suggest that the severity of left ventric- 
ular damage plays a role in the development of left ventric- 
ular thrombus. Resolution of thrombus was not correlated 
with improvement in global left ventricular function. There 
was no difference in the wall motion score of the 10 patients 
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Figure 4. Serial two-dimensional echocardiography (2DE) and left 
ventricular wall motion score (LVWMS) in 92 patients with and 
without left ventricular thrombosis (LVT). 
with persisting thrombus and that of the 12 patients whose 
thrombus showed resolution (Fig. 5). 
Table 1 shows the relation between the change in left 
ventricular apicul wall motion and thrombus resolution. 
Among the 12 patients with thrombus resolution, apical wall 
motion improved in 3, remained unchanged in 6 and wors- 
ened in 3. Among the 10 patients with persisting thrombus, 
Figure 5. Serial two-dimensional echocardiography (2DE) and left 
ventricular wall motion score (LVWMS) in 22 surviving patients 
with and without left ventricular thrombus (LVT) resolution during 
follow up. 
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Table 1. Relation Between Change in Left Ventricular Apical 
Wall Motion and Thrombus Resolution or Persistence on 
Two-Dimensional Echocardiography in 22 Patients 
First Study With LVT 12th Week Study 
Resolution of thrombus 
6 Akinetic 
4 Dyskinetic 
2 Aneurysm 
Persistence of thrombus 
5 Akinetic 
4 Dyskinetic 
1 Aneurysm 
I Normokinetic 
3 Akinetic 
2 Dyskinetic 
( 2 1 Akinetic Dyskinetic 
I Aneurysm 
! Aneurysm 
i 4 Dyskinetic 
I Aneurysm 
I 2 Dyskinetic 
Aneurysm 
1 Aneurysm 
LVT = left ventricular thrombus. 
apical wall motion worsened in 7 and improved in none (p < 
0.1). 
Fourteen of the 92 patients developed left ventricular 
aneqsm during the study, and thrombus was identified in 
IO (70%) of this group and in 20 (25%) of the 78 patients 
without aneurysm (p < 0.05). 
Clinical correlations and prognosis. The clinical charac- 
teristics of patients with and without left ventricular throm- 
bus are listed in Table 2. Differences were observed in 
maximal serum enzyme levels and Killip functional class. 
The number of Q waves in leads 1, aVL and V, to V, on the 
last ECG during hospitalization or just before death did not 
differ between these groups. 
Although the mortality rate in patients with (6 [20%] of 
30) and without (13 [21%] of 62) left ventricular thrombus 
was not different, all 6 patients with thrombus who died had 
detectable thrombus at the first or second echocardiographic 
study (Table 1). No patient died who developed thrombus 48 
to 72 h after acute myocardial infarction (p < 0.02). Left 
ventricular wall motion score calculated from the first echo- 
cardiogram (~24 h) was higher in patients with early throm- 
bus formation than in patients with late or no thrombus 
formation. 
Cerebral embolism occurred in two patients during hos- 
pitalizution, both with a protruding left ventricular thrombus 
and not treated with an oral anticoagulant agent. No other 
clinical thromboembolic event was noted during the study 
period. 
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Table 2. Clinical Data for 92 Patients With Early (~48 to 72 h), 
Late (>48 to 72 h) and No Formed Left Ventricular Thrombus 
LVT 
Early Late No LVT 
(n = 18) (n = 12) (n = 62) 
Male (%) 18 67 73 
Age (yr) 67 + IO 63 2 II 62 t 14 
Q waves (n)* 4.9 5 1.8 4.1 2 1.4 3.4 + 2.8 
Max CK (U/liter)* 2.374 f 1221 2,049 + I338 1,477 2 933 
Max MB CK (U/liter)* 210 * 106 159 2 110 145 2 101 
Max LDH (U/liter)* 1,281 * 623 941 ? 438 781 t 421 
LVWM score 1st 2DE* 14.8 + 3.3 10.3 t 4 9.9 2 4.1 
Killip class* 2.6 2 1.1 1.7 ? 0.7 1.9 ” 1.0 
Killip class III-IV (%) 61 18 30 
No LVT resolved (%) 33 41 0 
Mortality at 12 weeks (%) 33 0 21 
Beta-blockert (%) 17 50 42 
Calcium antagonist+ 0 8 II 
*Mean 2 SD; tmedication during hospitalization. LVT = left ventricular 
thrombosis; LVWMS = left ventricular wall motion score: CK = serum 
creatine kinase: LDH = serum lactate dehydrogenase: MB CK = creatine 
kinase isoenzyme; Q waves = number of Q waves in leads I, AVL and V, to 
V,; 2DE = two-dimensional echocardiography. 
Discussion 
Incidence of left ventricular thromhus. The 33% incidence 
rate of left ventricular thrombus in the 92 patients with 
anterior myocardial infarction in this study is concordant 
with the rate noted in previous reports (3,4,20,22,23). The 
echocardiogram performed at 2 weeks after infarction 
yielded the best result with respect to the percent of left 
ventricular thrombi diagnosed (96%) in the surviving pa- 
tients. With this week echocardiogram, we missed the 
thrombus in the four patients who died, the two patients with 
early resolution of thrombus and the patient with a later- 
formed thrombus. 
One limitation of our study is the lack of anatomic 
validation of the presence or absence of left ventricular 
thrombus. Two-dimensional echocardiography has a sensi- 
tivity ranging from 92% to 100% and a specificity ranging 
from 50% to 88%, as reported in two studies (1,2) with 
anatomic validation. Although equivocal echocardiographic 
images were considered negative, by repeated performance 
of echocardiographic studies, we limited equivocal studies to 
one case only. 
Left ventricular thrombus shape, treatment and follow-up. 
Thromboembolism is the only and, in most cases, disabling 
complication of left ventricular thrombosis. From previous 
reports (15,20,27-32), it is clear that patients with a protrud- 
ing or mobile rather than a flat mural thrombus are at risk for 
embolism. Haugland et al. (28) noted an embolization rate of 
60% in patients with a mobile thrombus and of 41% in 
patients with a protruding thrombus compared with 13% in 
patients with a mural thrombus. Other studies (3&33) indi- 
cate that thrombi that embolize are more likely to be 
protruding. Thus, it is of clinical importance to identify 
patients in this high risk group. In our study, 53% of the 30 
left ventricular thrombi showed protrusion and 47% were 
mural, a finding that is concordant with the results of other 
studies (20,25,28,32). Only two patients, both with a protrud- 
ing thrombus, had a clinical embolic event (a stroke 5 and 7 
days after myocardial infarction, respectively). No other 
embolic phenomenon was noted during the 12 week follow- 
up period in these study patients. This incidence of embo- 
lism (6.6%) is within the range reported by others 
(3,4,20,22,23,25). An explanation for this rather low inci- 
dence rate is that most of the patients received an antithrom- 
botic drug during the study, and only 10 patients had 
persisting thrombus during the 12 week study period. Al- 
though the value of oral anticoagulant therapy is not con- 
firmed, two review articles (34,35) suggested that the inci- 
dence of systemic embolism in patients with left ventricular 
thrombus who are treated with anticoagulant agents varies 
from 0% to 2% and in untreated patients from 24% to 33%, 
which warrants the use of such anticoagulant agents. Using 
frequent serial two-dimensional echocardiograms, Domeni- 
cucci et al. (25) demonstrated spontaneous changes in 
thrombus shape. In our study, thrombus shape changed 
spontaneously during hospitalization in 17% of the patients 
who were not treated with an anticoagulant agent and 7% of 
thrombi resolved. After hospital discharge, 53% of the left 
ventricular thrombi in the patients given anticoagulant ther- 
apy showed complete resolution, and 40% had significant 
change in thrombus shape or size. Of the untreated patients, 
40% had complete resolution of thrombus. 
Left ventricular wall motion and follow-up. Although se- 
rial two-dimensional echocardiography to detect and moni- 
tor left ventricular thrombus has been evaluated previously, 
this is the first study to use serial (more than two) left 
ventricular wall motion analysis (1,16,18,20,25,31). Left 
ventricular wall motion analysis in patients with and without 
left ventricular thrombus showed significant differences in 
our study. As expected, patients with thrombus had a higher 
left ventricular mall motion score on the first echocardio- 
gram. However, the wall motion score of these patients did 
not change significantly during follow-up as compared with 
that in patients without thrombus. In addition to having a 
significantly lower left ventricular wall motion score on the 
first echocardiogram patients without thrombus manifested 
significant improvement during follow-up. The reason for 
these findings is unclear. Thrombolytic therapy in the acute 
phase of infarction did not reduce the incidence of left 
ventricular thrombus and could not have been responsible 
for these changes. In any event, the absence of left ventric- 
ular thrombus predicted improvement of left ventricular 
function. 
Earlier reports (1+20,22,25) noted a high incidence of 
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left ventricle apical akinesia or dyskinesia in patients with 
left ventricular thrombus. In our series, apical akinesia or 
dyskinesia was observed within 24 h in 96% and 84% of 
patients with and without left ventricular thrombus, respec- 
tively. This finding may be a result of our selection criteria 
(anterior infarction with significant ST segment elevation). 
The percent of patients with an aneurysm was significantly 
higher in the thrombus group. These and earlier findings 
suggest that the combination of left ventricular wall motion 
abnormalities with subsequent stasis of blood, damaged 
endocardium and possibly a hypercoagulable condition in 
patients with acute myocardial infarction may be the main 
etiologic factors in early left ventricular thrombus formation. 
Of the 22 .sur\~i~ing puticnts with ventridrrr thrornhlrs 
whu were followed up jiir 12 weeks, 12 showed resolution of 
the thrombus. No differences in left ventricular wall motion 
score were noted between patients with persisting or re- 
solved thrombus. Thus, improvement in global left ventric- 
ular function did not play a role in thrombus resolution. This 
finding is unexpected and cannot be explained from our data. 
Analysis of the wall motion changes in the apical segment 
did not demonstrate significant improvement in patients with 
thrombus resolution as compared with results in patients 
with thrombus persistence. Worsening in apical wall motion 
was observed in 70% of the patients with persistent throm- 
bus and in 25% of those with thrombus resolution. Although 
there was a trend, this finding did not reach statistical 
significance. Apparently, other factors such as endocardial 
healing, asymptomatic embolization or changes in he- 
mostasis may play a role in the resolution of left ventricular 
thrombus. 
Clinical correlation and prognosis. In addition to left 
ventricular wall motion, maximal cardiac enzyme levels and 
Killip classification are important variables in relation to 
infarct size. In patients with left ventricular thrombus. we 
found higher peak enzyme levels, higher incidence of Killip 
class III to IV. higher left ventricular wall motion scores and 
more Q waves. These results indicate that patients with 
more severely impaired left ventricular function in acute 
myocardial infarction run a risk for left ventricular throm- 
bosis. 
The frequent two-dimensional echocardiographic exami- 
nations in our study during hospitalization allowed the 
identification of early (~48 to 72 h) and late (>48 to 72 h) left 
ventricular thrombi. Our results are identical to those of 
Spirit0 et al. (20) with respect to differences in mortality, 
Killip class III to IV and wall motion score. Six of the 18 
patients with an early-formed thrombus but none of the 12 
patients with a late-formed thrombus (p < 0.05) died. For- 
mation of left ventricular thrombus within 48 to 72 h of 
myocardial infarction occurred in patients with the most 
extensive infarction and was associated with a high mortality 
rate. With the analysis of left ventricular contractility and 
other clinical variables, these findings substantiate the con- 
elusion that detection of early formation of left ventricular 
thrombus identifies patients with a different clinical profile 
and prognosis. 
Conclusion. This large prospective study in 100 patients 
with a first acute anterior myocardial infarction indicates 
that left ventricular thrombus can be detected in 33% of such 
patients and carries a strong prognostic significance. Early 
thrornbus formation within 48 to 72 h was observed in 
patients with the most extensive infarction and was associ- 
ated with a poor prognosis. Most left ventricular thrombi in 
surviving patients were detected approximately 2 weeks 
after the onset of symptoms, indicating that the echocardio- 
grams obtained on day 3 and after 2 weeks had the greatest 
clinical value in assessing early prognosis and identifying left 
ventricular thrombus. 
The presence of left ventricular thrombus was correlated 
with persisting poor left ventricular function, whereas its 
absence predicted improved function. Left ventricular wall 
motion analysis as performed by serial two-dimensional 
echocardiography did not predict left ventricular thrombus 
regression or resolution. Significant change in shape, reduc- 
tion in size or resolution of the thrombus was noted in 93% 
of the patients treated with anticoagulant agents. Finally, the 
incidence of thromboembolism was low in this study, and 
occurred during hospitalization only in two patients with a 
protruding left ventricular thrombus. 
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